Arthur Kavanaugh
Impact in
- Rheumatology top 0.02%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 141
- Rheumatoid Arthritis Research and Therapies 127
- Systemic Lupus Erythematosus Research 37
- Spondyloarthritis Studies and Treatments 22
- Hematology 29
- Autoimmune and Inflammatory Disorders Research 28
- Co-authors
- Paul Emery (11 shared papers)Iain B. McInnes (8 shared papers)Daniel H. Solomon (7 shared papers)Vibeke Strand (8 shared papers)Gerd Rüdiger Burmester (3 shared papers)Gary S. Firestein (3 shared papers)Ronald van Vollenhoven (9 shared papers)Daniel Aletaha (5 shared papers)
- Journals
- Annals of the Rheumatic Diseases (27 papers)The Journal of Rheumatology (15 papers)Lara D. Veeken (8 papers)Arthritis Care & Research (6 papers)Arthritis Research & Therapy (5 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Arthur Kavanaugh
166 papers receiving 11.6k citations
Arthur Kavanaugh's Hit Papers
Peers
Comparison fields: 5 of 139
- Rheumatology 7.4k
- Hematology 2.1k
- Immunology 3.1k
- Genetics 873
- Radiology, Nuclear Medicine and Imaging 940
Countries citing papers authored by Arthur Kavanaugh
This map shows the geographic impact of Arthur Kavanaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Kavanaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Kavanaugh more than expected).
Fields of papers citing papers by Arthur Kavanaugh
This network shows the impact of papers produced by Arthur Kavanaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Kavanaugh. The network helps show where Arthur Kavanaugh may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur Kavanaugh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rheumatoid arthritis Hit paper breakdown → | 2018 | 1815 |
| 2 | The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial Hit paper breakdown → | 2006 | 832 |
| 3 | Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis Hit paper breakdown → | 2015 | 604 |
| 4 | Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial Hit paper breakdown → | 2005 | 599 |
| 5 | Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial Hit paper breakdown → | 2013 | 531 |
| 6 | Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study Hit paper breakdown → | 2009 | 493 |
| 7 | 2008 | 486 | |
| 8 | Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial Hit paper breakdown → | 2008 | 418 |
| 9 | 2002 | 352 | |
| 10 | 2000 | 340 | |
| 11 | 2010 | 324 | |
| 12 | 2008 | 288 | |
| 13 | Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics Hit paper breakdown → | 2014 | 279 |
| 14 | 2014 | 233 | |
| 15 | 2009 | 224 | |
| 16 | 2013 | 215 | |
| 17 | 2009 | 200 | |
| 18 | 2012 | 185 | |
| 19 | Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. | 2000 | 170 |
| 20 | 2010 | 137 |
About Arthur Kavanaugh
Arthur Kavanaugh is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 170 papers that have together received 12.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (127 papers), Systemic Lupus Erythematosus Research (37 papers), Autoimmune and Inflammatory Disorders Research (28 papers), Spondyloarthritis Studies and Treatments (22 papers), Biosimilars and Bioanalytical Methods (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). The work is most often cited by research in Rheumatology (7.4k citations), Hematology (2.1k citations), Immunology (3.1k citations), Genetics (873 citations) and Radiology, Nuclear Medicine and Imaging (940 citations). Arthur Kavanaugh has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Paul Emery, Iain B. McInnes, Daniel H. Solomon, Vibeke Strand, Gerd Rüdiger Burmester, Gary S. Firestein, Ronald van Vollenhoven, Daniel Aletaha, Josef S Smolen and Kazuhiko Yamamoto. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lara D. Veeken, Arthritis Care & Research and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.